Company Profile
AbbVie Inc Stock Price, News & Analysis
- Ticker:
- ABBV
- Exchange:
- NYSE
- Sector:
- 生物治疗,免疫治疗,神经科学治疗
- Location:
- Headquartered in North Chicago, Illinois and listed on NYSE, AbbVie is followed within the large-cap biopharmaceutical universe for its mix of commercial scale and specialty-disease exposure.
Stock performance
234.76 USD (+2.07%)
Close
Last updated: June 23, 2026 at 00:00
414.77B USD
Market cap
Why the stock is moving
ABBV is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
AbbVie is a large-cap pharmaceutical company with major exposure to immunology, aesthetics, and neuroscience. Investors focus on how the company balances commercial durability with ongoing pipeline replacement.
Geographic Base and Sector Classification
Headquartered in North Chicago, Illinois and listed on NYSE, AbbVie is followed within the large-cap biopharmaceutical universe for its mix of commercial scale and specialty-disease exposure.
Business Model Characteristics
AbbVie combines commercial cash flow with pipeline and business-development decisions. The market watches earnings, launch cadence, and whether new products can offset lifecycle pressure from mature assets.
Position Within the Biotechnology Landscape
Compared with clinical-stage biotech names, AbbVie sits on the mature end of the landscape, where portfolio durability and replacement cycle management are central.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AbbVie Inc (ABBV)?
AbbVie Inc (ABBV) most recently closed at 234.76 USD, a +2.07% move versus the previous session.
What is the market cap of AbbVie Inc (ABBV)?
AbbVie Inc currently has a market capitalization of 414.77B USD on BioPharmSignal.
What does AbbVie Inc do?
AbbVie is a large-cap pharmaceutical company with major exposure to immunology, aesthetics, and neuroscience. Investors focus on how the company balances commercial durability with ongoing pipeline replacement.
On which exchange is ABBV stock listed?
AbbVie Inc (ABBV) is associated with NYSE, Headquartered in North Chicago, Illinois and listed on NYSE, AbbVie is followed within the large-cap biopharmaceutical universe for its mix of commercial scale and specialty-disease exposure., 生物治疗,免疫治疗,神经科学治疗.
What is AbbVie?
AbbVie is a large-cap pharmaceutical company with major exposure to immunology, aesthetics, and neuroscience.
Which conditions is AbbVie Inc targeting with AbbVie?
AbbVie Inc is associated with immunology, neuroscience based on its company overview and current catalyst commentary.
What is Investors?
Investors focus on how the company balances commercial durability with ongoing pipeline replacement.